Diseases

"By strategically investing in a comprehensive pipeline, Cephalon will offer therapies that could address unmet medical needs and treat more patients who suffer from serious illnesses."

Kevin Buchi
Vice President
Global Branded Products

Top page

You are now leaving www.cephalon-europe.com.


Links to site outside of Cephalon EMEA are provided as a resource to the viewer. Cephalon EMEA accepts no responsability for the content of linked sites.


OK Cancel